.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Johnson and Johnson
Teva
Healthtrust
Farmers Insurance
Mallinckrodt
Chinese Patent Office
Argus Health
Federal Trade Commission

Generated: July 21, 2017

DrugPatentWatch Database Preview

NUVESSA Drug Profile

« Back to Dashboard

Which patents cover Nuvessa, and when can generic versions of Nuvessa launch?

Nuvessa is a drug marketed by Allergan Sales Llc and is included in one NDA. There are five patents protecting this drug.

This drug has thirteen patent family members in nine countries.

The generic ingredient in NUVESSA is metronidazole. There are eighteen drug master file entries for this compound. Eighty-one suppliers are listed for this compound. Additional details are available on the metronidazole profile page.

Summary for Tradename: NUVESSA

Patents:5
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list110
Patent Applications: see list9,454
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NUVESSA at DailyMed

Pharmacology for Tradename: NUVESSA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Sales Llc
NUVESSA
metronidazole
GEL;VAGINAL205223-001Mar 24, 2014RXYesYes7,893,097► SubscribeY ► Subscribe
Allergan Sales Llc
NUVESSA
metronidazole
GEL;VAGINAL205223-001Mar 24, 2014RXYesYes8,658,678► Subscribe ► Subscribe
Allergan Sales Llc
NUVESSA
metronidazole
GEL;VAGINAL205223-001Mar 24, 2014RXYesYes8,877,792► SubscribeY ► Subscribe
Allergan Sales Llc
NUVESSA
metronidazole
GEL;VAGINAL205223-001Mar 24, 2014RXYesYes9,198,858► Subscribe ► Subscribe
Allergan Sales Llc
NUVESSA
metronidazole
GEL;VAGINAL205223-001Mar 24, 2014RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: NUVESSA

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2009097143► Subscribe
Mexico2014000066► Subscribe
China103763925► Subscribe
European Patent Office2725904► Subscribe
Japan5986632► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: NUVESSA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0021Belgium► SubscribePRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Moodys
Cerilliant
Chinese Patent Office
Deloitte
McKinsey
AstraZeneca
Healthtrust
Citi
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot